References
- Zhao Y, Zhao B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev 2013;2013:316523.
- Simonyi A, He Y, Sheng W, et al. Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease. Mol Neurobiol 2010;41:73–86.
- Hernandes MS, Britto LR. NADPH oxidase and neurodegeneration. Curr Neuropharmacol 2012;10:321–7.
- Wilkinson BL, Landreth GE. The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J Neuroinflammation 2006;3:30. doi:10.1186/1742-2094-3-30
- Bruce-Keller AJ, Gupta S, Parrino TE, et al. NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal 2010;12:1371–82.
- Ansari MA, Scheff SW. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic Biol Med 2011;51:171–8.
- Block ML. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 2008;9:S8.
- Wingler K, Hermans JJ, Schiffers P, et al. NOX1, 2, 4, 5: counting out oxidative stress. Br J Pharmacol 2011;164:866–83.
- Ge J, Ding Z, Song Y, Wang F. Smoking dose modifies the association between C242T polymorphism and prevalence of metabolic syndrome in a Chinese population. PLOS ONE 2012;7:e31926.
- Inoue N, Kawashima S, Kanazawa K, et al. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998;97:135–7.
- Guzik TJ, West NE, Black E, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation. 2000;102:1744–7.
- Wyche KE, Wang SS, Griendling KK, et al. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004;43:1246–51.
- McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939–44.
- Yu JT, Mao CX, Zhang HW, et al. Genetic association of rs11610206 SNP on chromosome 12q13 with late-onset Alzheimer's disease in a Han Chinese population. Clin Chim Acta 2011;412:148–51.
- Liu HG, Liu K, Zhou YN, et al. Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population. Chin Med J (Engl) 2009;122:1369–74.
- Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998;19(6):589–601.
- Dinauer MC, Pierce EA, Bruns GA, et al. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Investig 1990;86:1729–37.
- Matsunaga-Irie S, Maruyama T, Yamamoto Y, et al. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 2004;27:303–7.
- Shimokata K, Yamada Y, Kondo T, et al. Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis 2004;172:167–73.
- Reitz C, Jun G, Naj A, et al. Variants in the ATP-binding cassette transporter (ABCA7), Apolipoprotein E ε4, and the risk of late-onset Alzheimer disease in African Americans. JAMA 2013;309:1483–92.
- Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997;23:134–47.